Eli Lilly's Optimism
Motley Fool Money
00:00
Eli Lilly's Financial Triumphs and Healthcare Innovations
This chapter explores Eli Lilly's record-breaking sales and earnings driven by successful weight loss and Alzheimer's treatments, while addressing the decline in COVID-19 drug sales. It also examines the debate over insurance coverage for obesity treatments and the implications for the healthcare system amid evolving consumer attitudes and economic pressures.
Play episode from 04:52
Transcript
